arginine has been researched along with Lymphoma, Non-Hodgkin in 58 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (36.21) | 18.7374 |
| 1990's | 22 (37.93) | 18.2507 |
| 2000's | 11 (18.97) | 29.6817 |
| 2010's | 4 (6.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biedroń, M; Butrym, A; Chachaj, A; Fleszar, MG; Gamian, A; Karczewski, M; Krzystek-Korpacka, M; Mazur, G; Rybka, J; Szuba, A; Wiśniewski, J; Wróbel, T | 1 |
| Fan, J; Ju, D; Li, Y; Sun, Y; Wang, S; Wang, Z; Xian, Z; Zeng, X; Zhang, G; Zhao, H | 1 |
| Dong, Z; Fidler, IJ; Gutman, M; Huang, S; Xie, K | 1 |
| Faller, DV; Mentzer, SJ; Perrine, SP | 1 |
| Desai, L; Mauritzen, CM; Ogawa, Y; Starbuck, WC; Taylor, CW | 1 |
| Burton, AF; Storr, JM | 1 |
| Landin, LM; Mashburn, LT | 1 |
| Biserte, G; Moschetto, Y; Sautiere, P; Tyrou, D | 1 |
| Brodsky, I; Dimitrov, NV | 1 |
| Efimov, ML; Iakovleva, SS; Ismailov, BI | 1 |
| Ahmad, AK; Azodi, M; Hui, P; Litkouhi, B; McCarthy, S; Ratner, E; Rutherford, T; Schwartz, PE; Xu, ML | 1 |
| Qiao, W; Wang, C; Wang, T; Xing, Y; Zhao, J | 1 |
| Fievet, MH; Gabarre, J; Junot, H; Malliti, M; Taright, N; Thuillier, A; Vernant, JP | 1 |
| Baars, JW; Carde, P; de Wolf-Peeters, C; Kluin-Nelemans, JC; Moser, EC; Noordijk, EM; Raemaekers, JM; Teodorovic, I; Tirelli, U; van Glabbeke, M | 1 |
| Bromberg, JE; Haaxma-Reiche, H; Harder, H; Holtel, H; Kluin-Nelemans, HC; Menten, J; Poortmans, P; van den Bent, MJ | 1 |
| Feng, FY; Gu, DZ; Hu, Y; Shi, YK; Wang, QL; Zhou, LQ | 1 |
| Arbion, F; Autret, A; Benboubker, L; Bonnaud, I; Cottier, JP; de Toffol, B; Debiais, S; Destrieux, C; Saudeau, D | 1 |
| Enschede, SH; Gregory, SA; Porter, C; Venugopal, P | 1 |
| Morrison, VA | 1 |
| Carbone, A; Crivellari, D; Franchin, G; Galligioni, E; Grigoletto, E; Tirelli, U; Trovò, M; Tumolo, S; Veronesi, A; Volpe, R | 1 |
| Carbone, A; Galligioni, E; Grigoletto, E; Tirelli, U; Trovo, MG; Veronesi, A; Volpe, R | 1 |
| Kondrat'eva, NA; Maiakova, SA; Makhonova, LA; Vialushkin, BIa | 1 |
| Gershanovich, ML; Kondrat'ev, VB; Kondrat'eva, NA; Lebedev, VN; Vialushkin, VIa | 1 |
| Babare, R; Carbone, A; Lazzarini, R; Merola, MC; Monfardini, S; Talamini, R; Tirelli, U; Zagonel, V | 1 |
| Bron, D; Carde, P; de Bock, R; De Wolf-Peeters, C; Delmer, A; Keunig, JJ; Keuning, JJ; Somers, R; Thomas, J; Tirelli, U | 1 |
| Bijnens, L; Hagenbeek, A; Kluin-Nelemans, JC; Meerwaldt, JH; Noordijk, EM; Peeters, CD; Pittaluga, S; Somers, R; Teodorovic, I; van Glabbeke, M | 1 |
| Reiter, A | 1 |
| Katou, H; Kuwabara, H; Miyaguchi, M; Sakai, S; Sakamoto, H; Yamauchi, A | 1 |
| Muggia, FM | 1 |
| Crist, WM; Pratt, CB; Pui, CH; Rivera, GK; Santana, VM | 1 |
| Almeida, MT; Britto, JL; Cristofani, LM; Maksoud, JG; Maluf, PT; Manissadjian, A; Odone Filho, V; Pontes, E | 1 |
| Gerrits, WB; Haak, HL; Kerkhofs, H; Wijermans, PW | 1 |
| Andersen, J; Chervenick, P; Gordon, LI; Gregory, S; Hahn, RG; Mazza, J; O'Connell, MJ | 1 |
| Smith, PJ; Stevens, M; Tiedemann, K; Toogood, IR | 1 |
| Bosq, J; Carde, P; Cosset, JM; Decaudin, D; Dhermain, F; Girinsky, T; Hayat, M; Juliéron, M; Koscielny, S; Munck, JN | 1 |
| Biron, P; Bordessoule, D; Coiffier, B; Gisselbrecht, C; Guerci, A; Herbrecht, R; Kerneis, Y; Lederlin, P; Reyes, F; Sebban, C; Tilly, H | 1 |
| Bijnens, L; Bron, D; Carde, P; Cosset, JM; Hagenbeek, A; Kluin-Nelemans, JC; Meerwaldt, JH; Noordijk, EM; Somers, R; Teodorovic, I; Thomas, J | 1 |
| Bastion, Y; Blanc, M; Blay, JY; Bordessoule, D; Brice, P; Brière, J; Coiffier, B; Deconinck, E; Divine, M; Dumontet, C; Lederlin, P; Salles, B; Sebban, C; Tilly, H | 1 |
| Ji, S; Ji, Y; Ju, X | 1 |
| McNeil, C | 1 |
| Anastasopoulou, A; Bron, D; Carbone, A; Carde, P; Kluin-Nelemans, HC; Maes, B; Musson, H; Noordijk, EM; Roozendaal, KJ; Teodorovic, I; Thomas, J; Zagonel, V | 1 |
| di Gennaro, G; Nasti, G; Schioppa, O; Spina, M; Talamini, R; Tirelli, U; Vaccher, E; Vultaggio, G | 1 |
| Ericsson, SM; Glimelius, BL; Larsson, RL; Nygren, HP; Sundström, C | 1 |
| Amiel, JL; Hayat, M; Mathé, G; Pouillart, P; Schwarzenberg, L; Tubiana, M | 1 |
| Charron, D; Dumonchel, P; Jorry, F; Laurens, A; Martola, R; Thevenot, J | 1 |
| Albahary, C; Amiel, JL; Belpomme, D; de Vassal, F; Depierre, R; Hayat, M; Jasmin, C; Mathé, G; Misset, JL; Musset, M; Pouillart, P; Schwarzenberg, L | 1 |
| Cooper, IA; Ding, JC; Matthews, JP; Matthews, JR | 1 |
| Glick, JH; Gordon, LI; Horton, J; Rowe, JM; Smith, TJ; Spiers, AS; Weens, JH | 1 |
| Carde, P; de Pauw, B; de Wolf-Peeters, C; Kluin-Nelemans, JC; Meerwaldt, JH; Monconduit, M; Somers, R; Tanguy, A; Thomas, J; van Glabbeke, M | 1 |
| Bladé, J; Carreras, E; Cervantes, F; Grañena, A; Marín, P; Nomdedeu, B; Ribera, JM; Rozman, C; Sierra, J; Urbano-Ispizua, A | 1 |
| McVie, G; Muggia, FM | 1 |
| Anderson, J; Bloomfield, CD; Cooper, MR; Ginsberg, SJ; Gottlieb, AJ; Hurd, DD; Lachant, NA | 1 |
| Bernard, JF; Boivin, P; Brousse, N; Chastang, C; Desaint, B; Gaulard, P; Herrera, A; Renoux, M; Solal-Celigny, P | 1 |
| Barbieri, E; Emiliani, E; Gherlinzoni, F; Lauria, F; Mazza, P; Tabanelli, M; Tura, S; Zinzani, PL | 1 |
| Coleman, CN; Horning, SJ; Jacobs, C; Lewis, BJ; Rosenberg, SA; Tseng, A | 1 |
| Divine, M; Farcet, JP; Gaulard, P; Haioun, C; Jouault, H; Kuentz, M; Reyes, F | 1 |
| Canetta, R; Carbone, A; Tirelli, U; Veronesi, A; Zagonel, V | 1 |
| Amiel, JL; Carde, P; Cosset, JM; Habrand, JL; Hayat, M; Henry-Amar, M; Ozanne, F; Tubiana, M | 1 |
6 review(s) available for arginine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies.
Topics: Antineoplastic Agents; Antiviral Agents; Arginine; Butyrates; Clinical Trials as Topic; Combined Modality Therapy; Enzyme Induction; Epstein-Barr Virus Infections; Ganciclovir; Gene Expression Regulation, Neoplastic; Herpesvirus 4, Human; Humans; Lymphoma, Non-Hodgkin; Prognosis; Thymidine Kinase | 2001 |
Long-term efficacy of the CHVmP/BV regimen used for aggressive non-Hodgkin's lymphoma in three randomised EORTC trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Survival Analysis; Teniposide; Treatment Outcome; Vinblastine | 2004 |
Non-Hodgkin's lymphoma in the elderly. Part 2: treatment of diffuse aggressive lymphomas.
Topics: Age Factors; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Granulocyte Colony-Stimulating Factor; Humans; Longitudinal Studies; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Meta-Analysis as Topic; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Prevalence; Prognosis; Recombinant Proteins; Survival Rate; Teniposide; Vincristine | 2007 |
Therapy of B-cell acute lymphoblastic leukaemia in childhood: the BFM experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Clinical Trials as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Germany, West; Humans; Infant; Leukemic Infiltration; Lymphoma, Non-Hodgkin; Male; Meninges; Methotrexate; Multicenter Studies as Topic; Prednisolone; Prognosis; Remission Induction; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 1994 |
Teniposide: overview of its therapeutic potential in adult cancers.
Topics: Acquired Immunodeficiency Syndrome; Adult; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Etoposide; Female; Genital Neoplasms, Female; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Sarcoma, Kaposi; Teniposide | 1994 |
Epipodophyllotoxins in the treatment of childhood cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cytarabine; Etoposide; Humans; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Neoplasms; Neoplasms, Second Primary; Neuroblastoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Teniposide | 1994 |
19 trial(s) available for arginine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Peripheral Blood Stem Cell Transplantation; Positron-Emission Tomography; Predictive Value of Tests; Prednisolone; Prednisone; Proportional Hazards Models; Radiopharmaceuticals; Rituximab; Teniposide; Tomography, X-Ray Computed; Transplantation, Autologous; Treatment Outcome; Vincristine; Young Adult | 2010 |
Autologous stem cell transplantation following induction therapy with an anthracycline-based regimen including interferon-alpha for low-grade non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Drug Administration Schedule; Female; Humans; Interferon alpha-2; Interferon-alpha; Kaplan-Meier Estimate; Leukopenia; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Peripheral Blood Stem Cell Transplantation; Prednisone; Recombinant Proteins; Remission Induction; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine | 2004 |
[Results of a clinical study of an epipodophyllotoxin preparation (VM 26) in children with hemoblastoses].
Topics: Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Podophyllotoxin; Prednisolone; Teniposide; Time Factors | 1981 |
[Use of preparation VM 26 (epipodophyllotoxin) for treating lymphomas in children and adults].
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Hodgkin Disease; Humans; Infant; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Podophyllotoxin; Teniposide; Time Factors | 1981 |
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome; Vincristine | 1994 |
Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recombinant Proteins; Remission Induction; Survival Rate; Teniposide; Vincristine | 1995 |
Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma. The impact of advanced age and performance status.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Recurrence; Teniposide; Vincristine | 1993 |
A VM 26-based regimen for patients with previously untreated non-Hodgkin lymphoma. Prolonged disease-free survival in patients younger than 60 years of age: a phase II trial of the eastern Cooperative Oncology Group.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Survival Rate; Teniposide | 1993 |
Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Infant; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prednisolone; Remission Induction; Retrospective Studies; Survival Rate; Teniposide; Vincristine | 1993 |
Alternating chemotherapy and radiotherapy for limited-stage intermediate and high-grade non-Hodgkin's lymphomas: long-term results for 96 patients with tumors > 5 cm.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Patient Compliance; Pilot Projects; Prednisone; Prognosis; Prospective Studies; Radiotherapy; Teniposide; Time Factors | 1996 |
Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Risk Factors; Teniposide; Treatment Outcome; Vincristine | 1997 |
Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisolone; Prednisone; Prospective Studies; Survival Rate; Teniposide | 1997 |
[High-dose chemotherapy supported by peripheral blood stem cells to treat intermediate--and high-grade non-Hodgkin's lymphomas].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Cytarabine; Dexamethasone; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recombinant Proteins; Stem Cells; Teniposide | 1996 |
Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Europe; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Teniposide; Transplantation, Autologous; Treatment Outcome; Vincristine | 2001 |
Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.
Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Interactions; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Retrospective Studies; Teniposide; Treatment Outcome; Vincristine | 2001 |
Failure of intensive chemotherapy in poor prognosis non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Teniposide; Treatment Outcome; Vincristine | 1992 |
Treatment of advanced refractory lymphomas with a combination of carmustine, bleomycin, teniposide, dexamethasone, and cisplatin (the BBVDD regimen). An ECOG pilot study.
Topics: Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Dexamethasone; Drug Evaluation; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Pilot Projects; Salvage Therapy; Teniposide | 1991 |
Superiority of second over first generation chemotherapy in a randomized trial for stage III-IV intermediate and high-grade non-Hodgkin's lymphoma (NHL): the 1980-1985 EORTC trial. The EORTC Lymphoma Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Survival Rate; Teniposide; Vincristine | 1991 |
[Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spain; Survival Rate; Teniposide; Thioguanine; Vincristine | 1990 |
33 other study(ies) available for arginine and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Asymmetric and symmetric dimethylarginines and mortality in patients with hematological malignancies-A prospective study.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Biomarkers, Tumor; Case-Control Studies; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prognosis; Prospective Studies; Survival Rate; Young Adult | 2018 |
Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin's lymphoma cells.
Topics: Apoptosis; Arginase; Arginine; Autophagy; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Lymphoma, Non-Hodgkin; Recombinant Proteins; Ribosomal Protein S6 Kinases; Signal Transduction; TOR Serine-Threonine Kinases | 2013 |
Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362.
Topics: Adjuvants, Immunologic; Amino Acid Oxidoreductases; Animals; Apoptosis; Arginine; Drug Carriers; Drug Interactions; Enzyme Activation; Enzyme Induction; Female; Interferon-gamma; Liposomes; Liver Neoplasms, Experimental; Lymphoma, Non-Hodgkin; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Oligopeptides; omega-N-Methylarginine; Peptide Fragments; Recombinant Proteins; RNA, Messenger | 1995 |
Carboxyl-terminal sequence of the glycine-arginine-rich histone from bovine lymphosarcoma, Novikoff hepatoma and fetal calf thymus.
Topics: Amino Acids; Animals; Arginine; Bromine; Carcinoma, Hepatocellular; Cattle; Chemical Phenomena; Chemistry; Chromatography, Gel; Chromatography, Ion Exchange; Cyanides; Electrophoresis; Glycine; Histones; Liver Neoplasms; Lymphoma, Non-Hodgkin; Peptides; Species Specificity; Thymus Gland; Trypsin | 1969 |
The effects of arginine deficiency on lymphoma cells.
Topics: Animals; Arginase; Arginine; Carbon Radioisotopes; Cell Count; Cell Line; Cell Survival; Cells, Cultured; Citrulline; Leucine; Leukemia L1210; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Mice; Neoplasms, Experimental; Ornithine; Succinates; Thymidine; Tritium; Uridine | 1974 |
Inhibition of thymidine and basic amino acid metabolism in P1798 lymphosarcoma by L-asparaginase.
Topics: Animals; Arginine; Asparaginase; Biological Transport; Carbon Radioisotopes; Depression, Chemical; Escherichia coli; Female; Lymphoma, Non-Hodgkin; Lysine; Mice; Mice, Inbred BALB C; Sarcoma, Experimental; Thymidine; Time Factors; Tritium | 1974 |
[Primary structure of glycine-rich and arginine-rich histone isolated from chloroleukemic tumor of the rat].
Topics: Amino Acid Sequence; Amino Acids; Animals; Arginine; Cattle; Chromatography, Gel; Electrophoresis, Disc; Glycine; Histones; Leukemia, Experimental; Lymphoma, Non-Hodgkin; Neoplasm Transplantation; Rats; Sarcoma, Experimental; Swine; Thymus Gland | 1971 |
Asparagine metabolism in some lymphoproliferative disorders.
Topics: Adult; Alanine; Amino Acids; Arginine; Asparagine; Aspartic Acid; Blood Proteins; Carbon Dioxide; Carbon Isotopes; Child; Child, Preschool; Glutamates; Humans; Leukemia, Lymphoid; Lipids; Lymphocytes; Lymphoma, Non-Hodgkin | 1970 |
[Histochemical features of radio-resistant and radio-sensitive tumors].
Topics: Animals; Arginine; Female; Histidine; Histocytochemistry; Lymphoma, Non-Hodgkin; Neoplasm Proteins; Neoplasms, Experimental; Ovarian Neoplasms; Rats; Sarcoma, Experimental | 1969 |
Institutional review of primary non-hodgkin lymphoma of the female genital tract: a 33-year experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Doxorubicin; Female; Genital Neoplasms, Female; Gynecologic Surgical Procedures; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisolone; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies; Survival Analysis; Teniposide; Vincristine; Young Adult | 2014 |
[Treatment of malignant non-Hodgkin's lymphoma. Economic impact of rituximab (Mabthera) versus conventional chemotherapy].
Topics: Anemia; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Costs and Cost Analysis; Cyclophosphamide; Doxorubicin; Drug Hypersensitivity; Female; Hospitalization; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Prednisone; Retrospective Studies; Rituximab; Teniposide; Thrombocytopenia; Vincristine; Vomiting | 2003 |
Cognitive status and quality of life after treatment for primary CNS lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Carmustine; Case-Control Studies; Central Nervous System Neoplasms; Cognition Disorders; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Hydrocortisone; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelin Sheath; Neuropsychological Tests; Prospective Studies; Quality of Life; Teniposide | 2004 |
[Primary central nervous system lymphoma: a report of 28 patients].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Teniposide | 2004 |
A spinal cord intravascular lymphomatosis with exceptionally good outcome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Carmustine; Central Nervous System; Combined Modality Therapy; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Methylprednisolone; Paraplegia; Spinal Cord Neoplasms; Teniposide | 2004 |
A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients.
Topics: Adult; Age Factors; Aged; Asthenia; Drug Evaluation; Female; Humans; Leukopenia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia | 1984 |
Primary lymphoblastic lymphoma of the breast.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Teniposide; Vincristine | 1982 |
Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapy.
Topics: Age Factors; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cost-Benefit Analysis; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Infection Control; Length of Stay; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Safety; Teniposide; Treatment Outcome; Vincristine | 1994 |
[Evaluation of the method of treating non-Hodgkin's lymphoma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Survival Rate; Teniposide; Vincristine | 1994 |
Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Methotrexate; Prednisone; Recurrence; Remission Induction; Survival Rate; Teniposide; Thioguanine; Vincristine | 1994 |
Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Infections; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisolone; Teniposide | 1996 |
Non-Hodgkin's lymphoma trials in elderly look beyond CHOP.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisolone; Prednisone; Teniposide; Vincristine | 1998 |
Assessment of drug activity and proliferation ex vivo for prediction of outcome in aggressive non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biopsy; Bleomycin; Cell Division; Cyclophosphamide; Daunorubicin; Doxorubicin; Drug Evaluation; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Immunophenotyping; Ki-67 Antigen; Lymphoma, Non-Hodgkin; Methotrexate; Mitotic Index; Neoplasm Staging; Prednisone; Survival Rate; Teniposide; Treatment Outcome; Vincristine | 2002 |
Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV.
Topics: Adult; Antineoplastic Agents; Azirines; Bleomycin; Cyclophosphamide; Daunorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Procarbazine; Teniposide; Triethylenemelamine; Vinblastine; Vincristine | 1975 |
[Combination of adriamycin, VM 26, cyclophosphamide and prednisone in the treatment of hematosarcomas].
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Podophyllotoxin; Prednisone; Teniposide | 1977 |
[Adriamycin, VM 26, cyclophosphamide and prednisone (AVmCP) combination in the therapy of disseminated lymphoreticulosarcoma (Stages or topographical forms III and IV].
Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Seeding; Podophyllotoxin; Prednisone; Remission, Spontaneous; Teniposide | 1975 |
Treatment strategies in relation to drug action.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; DNA Topoisomerases, Type II; Etoposide; Hodgkin Disease; Humans; Leukemia; Lung Neoplasms; Lymphoma, Non-Hodgkin; Neoplasms; Podophyllotoxin; Teniposide | 1987 |
Treatment of refractory lymphoma with methotrexate, VM-26 (teniposide), procarbazine, and dexamethasone: Cancer and Leukemia Group B study 7902.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Evaluation; Female; Humans; Leucovorin; Leukopenia; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neutropenia; Procarbazine; Teniposide; Thrombocytopenia; Vincristine | 1988 |
Age as the main prognostic factor in adult aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Teniposide | 1987 |
Intensive chemotherapy regimen in high-grade non Hodgkin's lymphomas.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Teniposide; Vincristine | 1987 |
Treatment of refractory non-Hodgkin's lymphomas of unfavorable histology with teniposide, cytarabine, and cisplatin.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Drug Evaluation; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Teniposide | 1987 |
Failure of combination chemotherapy of advanced follicular (low-grade) non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Teniposide; Time Factors; Vincristine | 1987 |
Non-Hodgkin's lymphomas in the elderly: prospective studies with specifically devised chemotherapy regimens in 66 patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Podophyllotoxin; Prednimustine; Prospective Studies; Teniposide | 1987 |
An alternating chemotherapy and radiotherapy combination for non-Hodgkin's lymphomas of unfavourable histologies: feasibility and preliminary results.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Radiotherapy Dosage; Teniposide; Time Factors | 1985 |